R&D Systems™ Recombinant Human CD19 Fc Chimera Protein

Catalog No. 92-69C-D050

Supplier: R&D Systems™ 9269CD050

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

The Recombinant Human CD19 Fc Chimera Protein is derived from CHO. The Recombinant Human CD19 Fc Chimera Protein has been validated for the following applications: Bioactivity.

Order Info

The product is shipped at ambient temperature.

Specifications

• Accession Number: P15391
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2μm filtered solution in PBS and NaCl
• Gene ID (Entrez): 930
• Molecular Weight (g/mol): 77 to 92 kDa, reducing conditions
• Name: B4, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, CD19, CD19 antigen, CD19 molecule, CVID3, Differentiation antigen CD19, Leu-12, MGC12802, T-cell surface antigen Leu-12
• Quantity: 50μg
• Source: Chinese Hamster Ovary cell line,CHO-derived human CD19 protein, (N-terminus) Human CD19 (Glu21-Lys291) Accession &Num; P15391 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Regulatory Status: RUO
• Endotoxin Concentration: <0.10 EU per 1μg of protein by LAL method
• Biological Activity: 4 to 20μg/mL (ED 50)
• Product Type: Recombinant protein
• Conjugate: Unconjugated
• Species: Human
• Recombinant: Recombinant
• Protein Tag: No
• Purity or Quality Grade: >90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.

For Research Use Only